These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

803 related articles for article (PubMed ID: 33132655)

  • 1. Dynamic contrast-enhanced magnetic resonance imaging and diffusion-weighted imaging in the activity staging of terminal ileum Crohn's disease.
    Wu YC; Xiao ZB; Lin XH; Zheng XY; Cao DR; Zhang ZS
    World J Gastroenterol; 2020 Oct; 26(39):6057-6073. PubMed ID: 33132655
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diffusion and perfusion MRI quantification in ileal Crohn's disease.
    Hectors SJ; Gordic S; Semaan S; Bane O; Hirten R; Jia X; Colombel JF; Taouli B
    Eur Radiol; 2019 Feb; 29(2):993-1002. PubMed ID: 30019143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiparametric MRI for Staging of Bowel Inflammatory Activity in Crohn's Disease with MUSE-IVIM and DCE-MRI: A Preliminary Study.
    Mao L; Li Y; Cui B; Lu L; Dou W; Pylypenko D; Zhu J; Li H
    Acad Radiol; 2024 Mar; 31(3):880-888. PubMed ID: 37730492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravoxel incoherent motion diffusion-weighted imaging in quantitative evaluation of Ileal Crohn's disease - A comparison with dynamic contrast-enhanced magnetic resonance imaging and ileocolonoscopy.
    Sun P; Zhu D; Li J; Zhang J; Zeng M; Fang L; Ruan J; Zhao X; Shi Y; Wang S; Zhao B
    Magn Reson Imaging; 2023 Apr; 97():82-90. PubMed ID: 36608907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Can Dynamic Contrast-Enhanced MRI (DCE-MRI) and Diffusion-Weighted MRI (DW-MRI) Evaluate Inflammation Disease: A Preliminary Study of Crohn's Disease.
    Zhu J; Zhang F; Luan Y; Cao P; Liu F; He W; Wang D
    Medicine (Baltimore); 2016 Apr; 95(14):e3239. PubMed ID: 27057860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histogram Analysis Comparison of Monoexponential, Advanced Diffusion-Weighted Imaging, and Dynamic Contrast-Enhanced MRI for Differentiating Borderline From Malignant Epithelial Ovarian Tumors.
    He M; Song Y; Li H; Lu J; Li Y; Duan S; Qiang J
    J Magn Reson Imaging; 2020 Jul; 52(1):257-268. PubMed ID: 31922327
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of diffusion kurtosis imaging and quantitative dynamic contrast-enhanced MRI for the differentiation of breast tumors.
    Li T; Yu T; Li L; Lu L; Zhuo Y; Lian J; Xiong Y; Kong D; Li K
    J Magn Reson Imaging; 2018 Nov; 48(5):1358-1366. PubMed ID: 29717790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiparametric approach with diffusion-weighted imaging and dynamic contrast-enhanced MRI: a comparison study for differentiating between benign and malignant bone lesions in adults.
    Oh E; Yoon YC; Kim JH; Kim K
    Clin Radiol; 2017 Jul; 72(7):552-559. PubMed ID: 28325514
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravoxel Incoherent Motion and Dynamic Contrast-Enhanced Magnetic Resonance Imaging to Early Detect Tissue Injury and Microcirculation Alteration in Hepatic Injury Induced by Intestinal Ischemia-Reperfusion in a Rat Model.
    Yang J; Meng M; Pan C; Qian L; Sun Y; Shi H; Shen Y; Dou W
    J Magn Reson Imaging; 2021 Sep; 54(3):751-760. PubMed ID: 33749079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diffusion kurtosis MRI versus conventional diffusion-weighted imaging for evaluating inflammatory activity in Crohn's disease.
    Huang L; Li XH; Huang SY; Zhang ZW; Yang XF; Lin JJ; Jiang MJ; Feng ST; Sun CH; Li ZP
    J Magn Reson Imaging; 2018 Mar; 47(3):702-709. PubMed ID: 28577319
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Application evaluation of DCE-MRI combined with quantitative analysis of DWI for the diagnosis of prostate cancer.
    Ma XZ; Lv K; Sheng JL; Yu YX; Pang PP; Xu MS; Wang SW
    Oncol Lett; 2019 Mar; 17(3):3077-3084. PubMed ID: 30867737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diffusion-weighted MRI Enables to Accurately Grade Inflammatory Activity in Patients of Ileocolonic Crohn's Disease: Results from an Observational Study.
    Li XH; Sun CH; Mao R; Huang SY; Zhang ZW; Yang XF; Huang L; Lin JJ; Zhang J; Ben-Horin S; Feng ST; Chen MH; Li ZP
    Inflamm Bowel Dis; 2017 Feb; 23(2):244-253. PubMed ID: 28079618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Value of quantitative multiparametric MRI in differentiating pleomorphic adenomas from malignant epithelial tumors in lacrimal gland.
    Wang Y; Song L; Guo J; Xian J
    Neuroradiology; 2020 Sep; 62(9):1141-1147. PubMed ID: 32430642
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glioma grading capability: comparisons among parameters from dynamic contrast-enhanced MRI and ADC value on DWI.
    Choi HS; Kim AH; Ahn SS; Shin NY; Kim J; Lee SK
    Korean J Radiol; 2013; 14(3):487-92. PubMed ID: 23690718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative diffusion-weighted magnetic resonance enterography in ileal Crohn's disease: A systematic analysis of intra and interobserver reproducibility.
    Yu H; Shen YQ; Tan FQ; Zhou ZL; Li Z; Hu DY; Morelli JN
    World J Gastroenterol; 2019 Jul; 25(27):3619-3633. PubMed ID: 31367161
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Assessment of Prostate Cancer Aggressiveness Using a Combination of Quantitative Diffusion-Weighted Imaging and Dynamic Contrast-Enhanced Magnetic Resonance Imaging.
    Zhu G; Luo J; Ouyang Z; Cheng Z; Deng Y; Guan Y; Du G; Zhao F
    Cancer Manag Res; 2021; 13():5287-5295. PubMed ID: 34239327
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined diffusion-weighted imaging and dynamic contrast-enhanced MRI for differentiating radiologically indeterminate malignant from benign orbital masses.
    Xu XQ; Qian W; Ma G; Hu H; Su GY; Liu H; Shi HB; Wu FY
    Clin Radiol; 2017 Oct; 72(10):903.e9-903.e15. PubMed ID: 28501096
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Standard diffusion-weighted, intravoxel incoherent motion, and dynamic contrast-enhanced MRI of musculoskeletal tumours: correlations with Ki67 proliferation status.
    Zhan J; Hao D; Wang D; Yue B; Zhou R; Tian N; Liu M; Gao C; Xu W; Cui J
    Clin Radiol; 2021 Dec; 76(12):941.e11-941.e18. PubMed ID: 34579866
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distinguishing T1-2 and T3a tumors of rectal cancer with texture analysis and functional MRI parameters.
    Sun D; Wu X; Wang L; Li G; Huang J; Li Y
    Diagn Interv Radiol; 2022 May; 28(3):200-207. PubMed ID: 35748201
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Diffusion weighted imaging and perfusion weighted imaging in the differential diagnosis of benign and malignant renal masses on 3.0 T MRI].
    Xu X; Wang P; Ma L; Shao Z; Zhang M
    Zhonghua Yi Xue Za Zhi; 2015 Jan; 95(3):200-4. PubMed ID: 25877031
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 41.